Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-017072
Filing Date
2026-04-16
Accepted
2026-04-16 16:01:07
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4700
  Complete submission text file 0001493152-26-017072.txt   6125
Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Issuer) CIK: 0001857030 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17 YEHUDA HANASI TEL AVIV Israel 00000
Business Address
Hirschfeld Gideon (Reporting) CIK: 0002118447 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40614 | Film No.: 26867430